Patient-reported Quality of Life and Survival Outcomes in Prostate Cancer: Analysis of the ECOG-ACRIN E3805 Chemohormonal Androgen Ablation Randomized Trial (CHAARTED) is a research paper published in European Urology Oncology (2024). On theSindex it has a DataRank of 0.330. It has been cited 8 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.330
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIH
Grant: UG1CA180802
NIH
Grant: U10CA180794
NIH
Grant: UG1CA180799
NIH
Grant: UG1CA180847
NIH
Grant: UG1CA189828
NIH
Grant: UG1CA180795
NIH
Grant: UG1CA180867
NIH
Grant: U10CA180820
NCI NIH HHS
Grant: U10 CA180802
NCI NIH HHS
Grant: UG1 CA233277
NCI NIH HHS
Grant: U10 CA180795
NCI NIH HHS
Grant: U10 CA180847
NCI NIH HHS
Grant: U10 CA180799
NCI NIH HHS
Grant: U10 CA180867
FWCI
2.20
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals